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 
Abstract—Electronic health records (EHR’s) are only a first 
step in capturing and utilizing health-related data - the problem 
is turning that data into useful information.  Models produced 
via data mining and predictive analysis profile inherited risks 
and environmental/behavioral factors associated with patient 
disorders, which can be utilized to generate predictions about 
treatment outcomes.   This can form the backbone of clinical 
decision support systems driven by live data based on the actual 
population.  The advantage of such an approach based on the 
actual population is that it is “adaptive”.   Here, we evaluate the 
predictive capacity of a clinical EHR of a large mental 
healthcare provider (~75,000 distinct clients a year) to provide 
decision support information in a real-world clinical setting.  
Initial research has achieved a 70% success rate in predicting 
treatment outcomes using these methods. 
 
I. INTRODUCTION 
ECENT years have the seen the proliferation of 
electronic health records (EHR’s) across the mental 
healthcare field and the healthcare industry in general.  The 
current challenge is turning data collected within EHRs into 
useful information.  An EHR is only the first step – data must 
be leveraged through technology to inform clinical practice 
and decision-making.  Without additional technology, EHR’s 
are essentially just copies of paper-based records stored in 
electronic form.   
Centerstone, the largest community-based mental health 
provider in the United States, is conducting research and 
development on a number of real-time decision support 
systems – including areas such as clinical productivity and 
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optimal treatment selection – that combine elements of data 
mining and predictive modeling with actual clinical practice.  
Data mining can capture complex patterns about patients’ 
genetic, clinical, and socio-demographic characteristics, 
which can be used to generate predictions about treatment 
outcomes. As a result, inherited risks and 
environmental/behavioral factors associated with patient 
disorders can be profiled and used to construct the backbone 
of clinical decision support systems driven by live data based 
on the actual population.  
Beyond this, there is stark evidence of a 13-17 year gap 
between research and practice in clinical care [1].  This 
reality suggests that the current methods for moving scientific 
results into actual clinical care are lacking. Furthermore, 
evidence-based treatments derived from such research are 
often out-of-date by the time they reach widespread use and 
don’t always account for real-world variation that typically 
impedes effective implementation [2].  Indeed, these issues 
have been a major reason for the push for clinical decision 
support in healthcare.  However, many of the current decision 
support systems rely on expert-based or standards-based 
models, rather than data-driven ones.  The former are based 
on statistical averages or expert opinions of what works for 
groups of people in general, whereas data-driven models are 
essentially an individualized form of practice-based evidence 
drawn from the live population.  The latter falls within the 
concept of “personalized medicine.”  
The ability to adapt specific treatments to fit the 
characteristics of an individual’s disorder transcends the 
traditional disease model.  Prior work in this area has 
primarily addressed the utility of genetic data to inform 
individualized care.  However, it is likely that the next 
decade will see the integration of multiple sources of data - 
genetic, clinical, socio-demographic – to build a more 
complete profile of the individual, their inherited risks, and 
the environmental/behavioral factors associated with disorder 
and the effective treatment thereof [3].  Indeed, we already 
see the trend of combining clinical and genetic indicators in 
prediction of cancer prognosis as a way of developing 
cheaper, more effective prognostic tools [4], [5], [6].   
However, data mining alone – or clinical decision support 
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alone – are only components of a larger potential system.  
Utilizing them in conjunction creates a system of real-time 
data-driven clinical decision support, or “adaptive decision 
support.”  The result is a more responsive and relevant 
model, essentially representing a form of rudimentary 
artificial intelligence that “lives” within the clinical system, 
can “learn” over time, and can adapt to the variation seen in 
the actual real-world population.  The approach is two-
pronged – both developing new knowledge about effective 
clinical practices as well as modifying existing knowledge 
and evidence-based models to fit real-world settings.   
Continuous improvement of clinical decision support and 
advancement of clinical knowledge are seen as key features 
for future systems [7].   In terms of actual application, 
modeling can be used to support clinical decisions provided a 
flexible, adaptable IT framework can consolidate data from 
different sources.  Typically, data warehousing provides such 
an infrastructure.  As opposed to the EHR, a data warehouse 
does not have to be tied to a single provider organization, 
increasing its power, scope and utility.  Patterns learned from 
past experience can then be applied to new clients as they 
enter the system (Fig. 1). 
 
In this study, we describe data mining and predictive 
modeling work that utilizes clinical indicators to predict 
client outcomes within the Centerstone system.  Those 
algorithms can then be applied to new clients to aid in 
selection of the optimal clinical treatment based on a number 
of possible “service packages”.  This approach was cross-
diagnostic, and the services distinguished only at a gross 
level (therapy, medical, case management).  Nonetheless, 
results indicate the approach as a promising avenue of 
research.  The initial work was necessitated by changes to a 
state-run payor (non-Medicaid “Safety Net”) in the state of 
Tennessee, which compelled Centerstone to optimize certain 
services for the patients most in need.  The goal was thus to 
determine the probability that a given set of services would 
result in average or above-average outcomes for a particular 
client and service package.  This method would provide 
clients with the best probability of positive outcomes while 
minimizing use of services unlikely to result in a positive 
outcome, increasing the availability of limited resources for 
other clients.  
II. METHODS  
A. Data Extraction 
Data was extracted from Centerstone’s electronic health 
record into a specialized schema in the data warehouse for 
data mining applications.  The target variable was the follow-
up CARLA outcome measure (Centerstone Assessment of 
Recovery Level – Adult) at 6 months post baseline.  The 
CARLA is a measure of level of recovery developed and 
validated by clinical experts at Centerstone. Using the 
CARLA, clinicians provide a systematic rating of client 
symptoms, functioning, supports, insight, and engagement in 
treatment.  Predictor variables initially extracted for the 
analysis included Baseline CARLA Score, Gender, Race, 
Age, Baseline Tennessee Outcomes Measurement System 
(TOMS) Symptomatology Score, Baseline TOMS 
Functioning Score, Previous Mobile Crisis Encounter 
(binary, yes/no), Diagnosis Category, Payor, Location, 
County , Region Type (Urban or Rural), Service Profile 
(types of services received) and Service Volume (amount of 
services received).  The initial sample was delimited to June 
1, 2008 through approximately June 1, 2009 and included 
only new intakes at time of baseline CARLA (had not seen 
previously in Centerstone’s clinics since at least 2001).  After 
these various filters were applied and data was screened for 
missing key fields (such as the CARLA at both baseline and 
follow-up), the final sample size for initial modeling was 423.  
  
B. Data Modeling 
After the initial data extraction and calculations were 
made, data was loaded into KNIME (Version 2.1.1) [9], an 
advanced data mining, modeling, and statistical platform.  
The initial analysis focused on the change in CARLA scores 
over time.  The primary question was whether clients would 
obtain average or better outcomes based on services received 
(or vice versa, worse outcomes).  As such, the target variable 
– improvement in clinical outcome – was discretized into a 
binary variable of plus/minus the mean (equivalent to equal 
bins classification).  The consequences and assumptions of 
reduction to a binary classification problem are addressed in 
[6], noting that the issues of making such assumptions are 
roughly equivalent to making such assumptions around 
normal distributions.  All predictor variables were z-score 
normalized.  Subsequently, all predictor variables were either 
1) not discretized (labeled “Bin Target”), or 2) discretized 
via CAIM (Class-Attribute Interdependence Maximization).  
CAIM is a form of entropy-based discretization that attempts 
 
Fig. 1.  Clinical Decision Support – Data Flow Diagram 
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to maximize the available “information” in the dataset by 
delineating categories in the predictor variables that relate to 
classes of the target variable.  By identifying and using 
patterns in the data itself, CAIM has been shown to improve 
classifier performance [8].  It should be noted that not all 
models are capable of handling both discretized and 
continuous variables, and thus both methods were not applied 
to all modeling methods.  Additionally, some methods, such 
as certain kinds of neural networks or decision trees, may 
dynamically convert numeric variables into binary or 
categorical variables as part of their modeling process.  As 
such, even when no pre-discretization was performed, it may 
have occurred within the modeling process itself. 
Multiple models were constructed on the dataset to 
determine optimal performance using both native, built-in 
KNIME models as well as models incorporated from WEKA 
(Waikato Environment for Knowledge Analysis; Version 
3.5.6) [10]. Models were generally run using default 
parameters, though some experimentation was performed to 
optimize parameters.  Namely, in the results shown here, 
there were three exceptions: 1) Bayesian Network – K2 was 
set MaxParents=3, 2) MP Neural Network was set 
Decay=True, and 3) K-Nearest Neighbors as set KNN=5. 
Models tested included Naïve Bayes[10], HNB (Hidden 
Naïve Bayes [11]), AODE (Aggregating One-Dependence 
Estimators [12]), Bayesian Networks [10], Multi-layer 
Perceptron neural networks [10], Random Forests [13], J48 
Decision Trees (a variant of the classic C4.5 algorithm [14]), 
Log Regression, and K-Nearest Neighbors [15],  
Additionally, ensembles were built using a combination of 
Naïve  Bayes, Multi-layer Perceptron neural network, 
Random Forests, K-nearest neighbors, and logistic 
regression, employing forward selection optimized by AUC 
[16].  Voting by committee was also performed with those 
same five methods, based on maximum probability [17].  Due 
to the number of models used, detailed explanations of 
individual methods are not provided here for brevity, but can 
be found elsewhere (e.g. [10] and [18], and references 
therein).   
C. Model Evaluation 
Model performance was determined using 10-fold cross-
validation [10].  All models were evaluated using multiple 
performance metrics, including raw predictive accuracy; 
variables related to standard ROC (receiver operating 
characteristic) analysis, the AUC (area under the curve), the 
true positive rate, and the false positive rate [19] and Hand’s 
H [20].  The data mining methodology and reporting is in 
keeping with recommended guidelines [21], [22], such as the 
proper construction of cross-validation, incorporation of 
feature selection within cross-validation folds, testing of 
multiple methods, and reporting of multiple metrics of 
performance, among others.  
Additionally, some of the better performing models were 
evaluated using feature selection prior to modeling (but 
within each cross-validation fold).  The feature selection 
methods used include univariate filter methods (Chi-squared, 
Relief-F), multivariate subset methods (Consistency-Based –
Best First Search, Symmetrical Uncertainty Correlation-
Based Subset Evaluator) and wrapper-based (Rank Search 
employing Chi-squared and Gain Ratio).  The advantages and 
disadvantages of these different types of feature selection are 
well-addressed elsewhere [23].  
 
III. RESULTS  
 
The results of the various combinations of modeling 
method and discretization can be seen in Table 1, sorted by 
AUC.  The highest accuracies are between 70-72%, with 
AUC values ranging .75-.79.  It should also be noted that the 
Spearman’s rank-order correlation between AUC and Hand’s 
H was .977 (p<.01), indicating little divergence between the 
two measures, at least on this particular dataset.  Hand [20] 
has indicated that these two measures will diverge when 
misclassification costs vary across methods.  We found no 
evidence of that in this case, or at least that the issue was not 
significant.  These initial results suggest a predictive capacity 
of the current EHR data within Centerstone.  We suspect that 
utilizing outcome measures designed to specifically measure 
change over time will improve this capacity. 
 
 Table 1: Model Performance 
Model Binning Accuracy AUC TP rate FP rate H
 AODE CAIM 72.3% 0.7769 74.6% 32.6% 0.2739
 Lazy Bayesian Rules CAIM 71.2% 0.7741 75.2% 36.2% 0.2695
 Naïve Bayes CAIM 71.6% 0.7706 76.5% 36.5% 0.2705
 Bayes Net - K2 CAIM 70.7% 0.7690 75.4% 37.4% 0.2550
 Bayes Net - K2 Bin Target 70.4% 0.7677 75.7% 38.1% 0.2561
 Ensemble CAIM 70.9% 0.7604 76.9% 38.1% 0.2452
 Naïve Bayes Bin Target 68.6% 0.7587 74.7% 41.0% 0.2410
 Bayes Net - TAN CAIM 70.0% 0.7567 73.3% 37.0% 0.2302
 Bayes Net - TAN Bin Target 69.7% 0.7561 73.4% 37.6% 0.2392
 MP Neural Net CAIM 70.7% 0.7534 75.6% 37.6% 0.2273
 Ensemble Bin Target 70.2% 0.7500 74.5% 37.6% 0.2195
 Classif via Linear Reg Bin Target 68.8% 0.7486 71.5% 37.6% 0.2356
 MP Neural Net Bin Target 69.5% 0.7467 73.0% 37.7% 0.2368
 K-Nearest Neighbor CAIM 69.5% 0.7377 73.6% 38.4% 0.2093
 Vote CAIM 68.1% 0.7362 72.7% 40.5% 0.2011
 Random Forest Bin Target 66.0% 0.7238 70.3% 43.1% 0.2040
 Random Forest CAIM 67.8% 0.7222 71.7% 40.1% 0.1896
 Log Regression CAIM 67.8% 0.7206 77.7% 47.9% 0.1812
 Log Regression Bin Target 67.1% 0.7117 71.7% 41.7% 0.1799
 J48 Tree CAIM 68.1% 0.6813 71.5% 39.4% 0.1688
 Vote Bin Target 63.4% 0.6609 76.2% 57.1% 0.1239
 J48 Tree Bin Target 66.9% 0.6544 72.4% 32.6% 0.1487
 K-Nearest Neighbor Bin Target 63.8% 0.6359 65.9% 44.2% 0.0786
10X Cross-Val (partitioned)
 
These models were then applied to a series of pre-
determined “service packages” that most common clients 
receive.  Client data is Cartesian-joined to the service 
packages to produce predictions for combinations of each 
and each service package, in essence a “what if” analysis.  
The results of one of the higher performing models by AUC 
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(Bayesian Network – K2) were used to generate predictive 
information at the time of intake for the clinician.  
Implementation with the live system is being addressed in a 
separate, upcoming study (data not shown).  However, 
examples of these predictions (based on actual data) can be 
seen in Figures 2 and 3. 
 
 
Fig. 2. Example 1 of treatment   recommendations using 
pre-set “service packages” 
 
 
Fig. 3. Example 2 of treatment   recommendations using 
pre-set “service packages” 
The results of feature selection were mixed (data not 
shown).  Although some methods were able to produce 
similar performance using smaller, more parsimonious 
feature sets than the full feature set models (most notably 
wrapper-based approaches), they generally did not improve 
performance significantly.  Additionally, the selected feature 
sets displayed a marked degree of variability across 
methodologies.  This is a common issue, to be expected with 
complex problems [24], [25].  In many domains there are 
potentially multiple models/feature sets that can produce 
comparably good results. 
 
IV. CONCLUSION 
Predictive modeling on live EHR data from a large 
community-based mental health provider has revealed the 
capacity of such systems to be used as the basis for an 
“adaptive” clinical decision support framework.   Even 
without work to enhance the EHR, models were built with 
over 70% accuracy and .75 AUC in predicting optimal 
clinical treatments.  It is likely through such an approach that 
the true potential of EHR’s can be realized.  Indeed, even 
recent popular media articles are picking up on this 
distinction between current EHR’s and their trumpeted 
potential (“Little Benefit Seen, So Far, in Electronic Patient 
Records” New York Times, 11/15/2009).   
 Without individualized care recommendations that have 
the capacity to rapidly incorporate changing evidence, 
adoption of evidence-based practice and treatment guidelines 
will continue to occur at a glacial pace. While there are many 
barriers to adoption of systematic treatment 
recommendations, one of the primary failings of common 
treatment recommendations is that they are based on 
statistical averages (e.g., “70% of people improve with 
medication X”). While those guidelines are helpful, 
practicing clinicians are keenly aware that treatments that 
have been shown to be highly effective in clinical trial 
populations are not always effective with individuals in real-
world settings. This is particularly true when the source 
research failed to adequately address variation due to gender, 
race, ethnicity, or a multitude of other potential factors. 
When recommended treatments don’t work, clinicians are 
frequently left to make critical decisions where research 
evidence is lacking.  
 The integration of electronic health records with 
rigorous data modeling as described herein can complement 
traditional research methods by filling gaps in knowledge, by 
suggesting new and possibly unanticipated avenues for 
systematic research, and by enabling rapid deployment of 
personalized evidence in field settings. New innovations for 
individualized care can literally be integrated into predictive 
models overnight, as opposed to the decades that research 
evidence often takes to diffuse into common practice. This is 
key to leveraging electronic health data.  Without modeling, 
EHR’s are only informative of what occurred in the past, not 
predictive of the future.  Without that predictive capacity, it 
cannot be used by clinicians as actionable information. 
 One limitation of this approach is that it requires large 
and diverse populations, diversity in practice, and reliable 
data. A small medical practice or group practice could not 
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generate enough data to produce reliable and replicable 
findings. It is therefore important for provider organizations 
to consider how to aggregate their data so that predictive 
models may be developed and fed back into local electronic 
health records. Privacy and security of health information 
will have to be paramount, or the risks to individual privacy 
may outweigh the collective benefit of data aggregation and 
prevent meaningful advances in care. 
 It is also worth noting that these models actually benefit 
from natural variation in clinical practice. The current drive 
toward standardization and consistency in treatment may 
actually inhibit innovation that would be identified through 
modeling efforts. While health research is generally informed 
by clinical theory and practice, most practice occurs outside 
the purview of academic medicine, and many exceptional 
clinical practitioners do not conduct research or publish 
innovations they may develop with their patients. Modeling 
can identify emerging clinical practices that are especially 
promising, and may accelerate the process of dissemination 
from one clinician to another.   
 In the work described here, the initial model was built 
across all diagnoses - including diagnosis used as a predictor 
variable – but work is proceeding to focus on building 
models that make personalized clinical predictions within 
diagnostic-specific groups.  Furthermore, research is 
continuing into analyzing more specific questions, moving 
from – “does the client need medications” – to “which 
medications are most likely to be effective for this particular 
individual”.  Mixing genetic (e.g. microarray) and clinical 
indicators, rather than using one or the other, is the most 
likely long-term avenue, although if and how these data 
sources should be combined is still a subject of intense 
debate [4], [5], [6]. 
 The purpose of this study was to test the feasibility of 
building clinically predictive models using data already 
existent in the EHR.  After this initial work, a new study is 
currently underway using improved outcome measures that 
are putatively better indicators of clinical improvement 
(CDOI – Client-Directed Outcome-Informed, [26]).  This is 
to be followed by the first controlled pilot study on actual 
implementation of this data-driven decision support model 
specifically for patients with depression at certain clinical 
sites.  In addition, we are developing a national data 
warehouse across several major mental healthcare providers 
from Michigan to Colorado to Arizona, in partnership with 
the Centerstone Research Institute’s Knowledge Network, a 
technology-based alliance of providers, academic 
researchers, and industry leaders.   Funding is also being 
sought to develop a gene expression database on a large 
portion of Centerstone’s clinical population, likely starting 
with clients with depressive disorders or schizophrenia.  
These future efforts will help to improve and validate these 
models. 
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